All4NutraNo products in the cart.
All4NutraStartseite » Oral Excipients » Page 34
Abstract Dasatinib (DAS), a potent anticancer drug, has been subjected to formulation enhancements due to challenges such as significant first-pass...
Parkinson’s disease (PD) is a debilitating neurodegenerative disease primarily impacting neurons responsible for dopamine production within the brain. Pramipexole (PRA)...
Simvastatin (SV) is a statin drug that can effectively control cholesterol and prevent cardiovascular diseases. However, SV is water-insoluble, and...
Abstract Oral thin films (OTFs) are innovative dosage forms that have gained tremendous attention for the delivery of nutraceuticals. They...
ABSTRACT The aim of the present investigation was to enhance the aqueous solubility and dissolution rate of a poorly soluble...
This poster was presented at the PBP World Meeting 2024 by Glatt Pharmaceutical Services with the Utrecht Institute for Pharmaceutical...
Abstract Background Traumatic brain injury (TBI) is the most common cause of cognitive and behavioral deficits, disability, and mortality worldwide....
About our company The Gattefossé Group is a community of employees, all driven by a dual mission: the performance of...
Abstract Aim: The research aimed to design the glimepiride self-micro emulsifying drug delivery system (SMEDDS) for increased oral bioavailability in...
Abstract Swallowing oral solid dosage forms is challenging for those who have medication swallowing difficulties, including patients with dysphagia. One...
Copyright: PharmaExcipients AG